lu af20513
Vaccineexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2015 (NCT02388152)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Amyloid beta A4 proteinImmunity, active
APP immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lu af20513
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03819699 | Phase 1 | Dec 12, 2018 | Lundbeck |
| NCT03668405 | Phase 1 | Jun 26, 2018 | Lundbeck |
| NCT02388152 | Phase 1 | Mar 1, 2015 | Lundbeck |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lundbeck | For profit | 3 | 3 | 1 | 2015 |
1 organizations
Page 1 / 1